Royal Bank Of Canada Lowers Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target to $420.00
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) had its price target dropped by Royal Bank Of Canada from $423.00 to $420.00 in a research note issued on Tuesday,Benzinga reports. The brokerage presently has a “sector perform” rating on the pharmaceutical company’s stock. Royal Bank Of Canada’s price objective points to a potential downside of 6.33% […]
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) had its price target dropped by Royal Bank Of Canada from $423.00 to $420.00 in a research note issued on Tuesday,Benzinga reports. The brokerage presently has a “sector perform” rating on the pharmaceutical company’s stock. Royal Bank Of Canada’s price objective points to a potential downside of 6.33% […]
-limited-logo-1200x675.png?v=20240522095703&w=240&h=240&zc=2){kind=logo}
